Actualités Lattice Biologics Ltd - LBL | Actions TSX Venture Exchange

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

Lattice Biologics Ltd. Announces Resignation of Director

Lattice Biologics Ltd. (TSX-V: LBL) (OTCBB: LBLTF) (“Lattice Biologics” or the “Company”) announces that Mr. Donald McInnes has resigned as a...

Lattice Biologics Signs Definitive Agreement with Alumina Partners for $6 Million At-Will Offering Facility

Lattice Biologics Ltd. (TSX-V: LBL) (OTCBB: LBLTF) (“Lattice Biologics” or the “Company”) is pleased to announce that it has entered into a...

Lattice Biologics to Evaluate Anti-Inflammatory Stem Cell Therapy Treatment of COVID-19 Lung Disease

Lattice Biologics Ltd. (TSX-V: LBL) (OTCQB: LBLTF) (“Lattice Biologics” or the “Company”) today announced that it plans to evaluate its amniotic...

Lattice Biologics Ltd. Reports Second Quarter 2019 Results

Lattice Biologics Ltd. (TSX-V: LBL) (OTCBB: LBLTF) (“Lattice Biologics” or the “Company”) announces financial results for Q2 2019...

Lattice Biologics Ltd. Announces Management Cease Trading Order is Revoked

Lattice Biologics Ltd. (TSX-V: LBL) (OTCBB: LBLTF) (“Lattice Biologics” or the “Company”) announces the Company has successfully filed all...

Lattice Biologics Ltd. Reports Fourth Quarter 2017, First Quarter 2018, and Year End 2017 Highlights

Gross Margins Increase to 66% Q1 2018 from 37% Q1 2017 Lattice Biologics Ltd. (TSX-V: LBL) (OTCBB: LBLTF) (“Lattice Biologics” or the...

Lattice Biologics Ltd. Announces Change in Director and Change in Status of Chief Operating Officer

Lattice Biologics Ltd. (TSX-V: LBL) (OTCQB: LBLTF) (“Lattice Biologics” or the “Company”) announces a change in its Board of Directors and...

Lattice Biologics Ltd. Reports Third Quarter 2017 Highlights

First profitable quarter of $.02 per share Lattice Biologics Ltd. (TSX-V: LBL) (OTCQB: LBLTF) (“Lattice Biologics” or the “Company”...

CORRECTING and REPLACING Notice of Lattice Biologics Ltd. Third Quarter 2017 Financial Results Conference Call

Financial results to be released after market on Tuesday, August 29, 2017 The conference call dial-in number in the release dated August...

Notice of Lattice Biologics Ltd. Third Quarter 2017 Financial Results Conference Call

Financial results to be released after market on Tuesday, August 29, 2017 Lattice Biologics Ltd. (TSX -V: LBL) (OTCQB: LBLTF) (the...

Lattice Biologics Ltd. Announces Change in Director and Chairman of Scientific Advisory Board

Lattice Biologics Ltd. (TSX-V: LBL) (OTCQB: LBLTF) (“Lattice Biologics” or the “Company”) announces a change in its Board of Directors and...

Lattice Biologics Ltd. Announces Move to Belgrade, Montana

Lattice Biologics Ltd. (TSX-V: LBL) (OTCQB: LBLTF) (“Lattice Biologics” or the “Company”) announces a relocation of its processing...

Grenville Strategic Royalty Announces Completion of Transaction to Restructure Lattice Biologics Investment

TORONTO, June 14, 2017 (GLOBE NEWSWIRE) -- Grenville Strategic Royalty Corp. (TSXV:GRC) (“Grenville” or...

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Lattice Biologics Ltd (LBL)

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

LBL Actualités

Lattice Biologics Ltd. Announces Resignation of Director

Lattice Biologics Signs Definitive Agreement with Alumina Partners for $6 Million At-Will Offering Facility

Lattice Biologics to Evaluate Anti-Inflammatory Stem Cell Therapy Treatment of COVID-19 Lung Disease

Lattice Biologics Ltd. Reports Second Quarter 2019 Results

Lattice Biologics Ltd. Announces Management Cease Trading Order is Revoked

Lattice Biologics Ltd. Reports Fourth Quarter 2017, First Quarter 2018, and Year End 2017 Highlights

Lattice Biologics Ltd. Announces Change in Director and Change in Status of Chief Operating Officer

Lattice Biologics Ltd. Reports Third Quarter 2017 Highlights

CORRECTING and REPLACING Notice of Lattice Biologics Ltd. Third Quarter 2017 Financial Results Conference Call

Notice of Lattice Biologics Ltd. Third Quarter 2017 Financial Results Conference Call

Lattice Biologics Ltd. Announces Change in Director and Chairman of Scientific Advisory Board

Lattice Biologics Ltd. Announces Move to Belgrade, Montana

Grenville Strategic Royalty Announces Completion of Transaction to Restructure Lattice Biologics Investment

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Lattice Biologics Ltd (LBL) Actualités

Lattice Biologics Ltd (LBL)

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

LBL Actualités

Lattice Biologics Ltd. Announces Resignation of Director

Lattice Biologics Signs Definitive Agreement with Alumina Partners for $6 Million At-Will Offering Facility

Lattice Biologics to Evaluate Anti-Inflammatory Stem Cell Therapy Treatment of COVID-19 Lung Disease

Lattice Biologics Ltd. Reports Second Quarter 2019 Results

Lattice Biologics Ltd. Announces Management Cease Trading Order is Revoked

Lattice Biologics Ltd. Reports Fourth Quarter 2017, First Quarter 2018, and Year End 2017 Highlights

Lattice Biologics Ltd. Announces Change in Director and Change in Status of Chief Operating Officer

Lattice Biologics Ltd. Reports Third Quarter 2017 Highlights

CORRECTING and REPLACING Notice of Lattice Biologics Ltd. Third Quarter 2017 Financial Results Conference Call

Notice of Lattice Biologics Ltd. Third Quarter 2017 Financial Results Conference Call

Lattice Biologics Ltd. Announces Change in Director and Chairman of Scientific Advisory Board

Lattice Biologics Ltd. Announces Move to Belgrade, Montana

Grenville Strategic Royalty Announces Completion of Transaction to Restructure Lattice Biologics Investment

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Supprimer les publicités